One68 Global Capital, LLC Aravive, Inc. Transaction History

One68 Global Capital, LLC

  • $0
  • Q3 2023

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020
SELL
$3.5 - $13.77 $59,199 - $232,905
-16,914 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$6.21 - $14.02 $105,035 - $237,134
16,914 New
16,914 $231,000

Others Institutions Holding ARAV

# of Institutions
2
Shares Held
28.1K
Call Options Held
0
Put Options Held
0
View Full List

About Aravive, Inc.

ARAV Quotes by TradingView
  • Ticker ARAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,518,300
  • Description
  • Aravive, Inc., a clinical-stage biopharmaceutical company, develops treatments for life-threatening diseases, including cancer and fibrosis in the United States. Its lead product candidate is batiraxcept, an ultrahigh-affinity, decoy protein that targets the GAS6-AXL signaling pathway, which is in Phase III clinical trial for the treatment of pl...
More about ARAV
Track This Portfolio

Track One68 Global Capital, LLC Portfolio

Follow One68 Global Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of One68 Global Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on One68 Global Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email